Discount cards and coupons mask sky-high drug costs

01/25/2013 | LearnVest

Prices on brand-name drugs were up more than 13% in September over the previous year, and drugmakers are increasingly developing treatments for rare diseases and pricing those drugs at hundreds of thousands of dollars per patient per year. Drugmakers increasingly offer discount cards and copay coupons to help patients afford expensive brand-name drugs, but commercial insurers bear the brunt of the costs -- a cycle that keeps health care spending high. The nation will pay an extra $32 billion on prescription drugs over the next 10 years unless the use of discount cards and coupons is halted, a PCMA study found.

View Full Article in: